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13.09.004Abstract Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) hold immense
promise for regenerative medicine due to their abilities to self-renew and to differentiate into all cell
types. This unique property is controlled by a complex interplay between transcriptional factors and
epigenetic regulators. Recent research indicates that the epigenetic role of non-coding RNAs
(ncRNAs) is an integral component of this regulatory network. This report will summarize ﬁndings
that focus on two classes of regulatory ncRNAs, microRNAs (miRNAs) and long ncRNAs
(lncRNAs), in the induction, maintenance and directed differentiation of ESCs and iPSCs.
Manipulating these two important types of ncRNAs would be crucial to unlock the therapeutic
and research potential of pluripotent stem cells.Introduction
Embryonic stem cells (ESCs) derived from the inner cell mass,
which possess the potential for unlimited proliferation and dif-
ferentiation into three germ layers, are the ideal cell source for
cell therapy [1–3]. The acquisition of human ESCs (hESCs),
however, requires the destruction of human embryos. There-
fore, possible immunological rejection or religious and ethical
concerns greatly hinder the pace of ESCs in basic and clinical
applications. In 2006, the Yamanaka group obtained inducedg J).
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ing Institute of Genomics, Chinese Apluripotent stem cells (iPSCs) with characteristics similar to
those of ESCs by overexpressing four exogenous factors
(Oct4, Sox2, c-Myc and Klf4) in ﬁbroblasts [4]. This method
of deriving patient-speciﬁc iPSCs from donor somatic cells re-
moves many of these medical, ethical and political obstacles,
creates disease-speciﬁc stem cells and provides a platform to
study molecular mechanisms of genetic diseases. Understand-
ing how these regulatory processes function in iPSCs would
help to accelerate the basic research and clinical applications
of iPSCs [5].
ESCs and iPSCs are characterized by their self-renewal and
differentiation into any cell type. Transcription factor net-
works and epigenetics (including DNA methylation, histone
modiﬁcations and ncRNAs) undergo a tremendous change
during this process [6–8]. ncRNAs can be classiﬁed into either
housekeeping or regulatory ncRNAs. Housekeeping ncRNAs
are most often constitutively expressed, which include transfer
RNAs (tRNAs), ribosomal RNAs (rRNAs), small nuclear
RNAs (snRNAs) and small nucleolar RNAs (snoRNAs).cademy of Sciences and Genetics Society of China. Production and hosting
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lncRNAs (>200 bp) and small ncRNAs (<200 bp) such as
miRNAs, endogenous small interfering RNAs (endo-siRNAs)
and PIWI-interacting RNAs (piRNAs) [9]. lncRNAs originate
from intronic, exonic, intergenic, intragenic, promoter regions,
30- and 50-untranslated regions (UTR) and enhancer sequences.
lncRNAs sometimes are bidirectional transcripts [10].
lncRNAs consists of intergenic ncRNAs, intronic ncRNAs,
natural antisense transcripts (NATs), pseudogene transcripts,
etc. Long intergenic ncRNAs (lincRNAs) are derived from
non-coding DNA sequences between protein-coding genes,
whereas intronic lncRNAs are transcribed from within introns
of protein-coding genes and NATs are transcribed from the
opposite strand of protein-coding sense transcripts [11,12].
Pseudogene transcripts can modulate the expression of their
counterpart genes through competing for endogenous RNA
(ceRNA) [13]. This review will focus on miRNAs and
lncRNAs.
miRNAs are hairpin-derived RNAs that are 20–24 nucleo-
tides (nt) long. They act at the RNA level by destabilizing and
repressing target RNAs via binding to the 30 UTRs, 50 UTRs
and coding sequences of the transcripts [14–17]. Nonetheless,
miRNAs can also enhance mRNA translation by binding to
the 50 UTRs [18]. Some miRNA genes are distributed as
clusters in the genome and thus these closely distributed
miRNAs are termed as the miRNA cluster. miRNA-coding
genes are transcribed into long primary miRNAs
(pri-miRNAs) by RNA polymerase II in the nucleus, and
then the Drosha-DiGeorge critical region-8 (DGCR8) com-
plex processed pri-miRNAs into precursors (pre-miRNAs)
of 60–70 nt in length. Drosha is a member of the ribonuclease
III family (RNase III) [19]. Drosha and its cofactor, DGCR8,
form a multiprotein complex called Microprocessor to medi-
ate the nuclear export. pre-miRNAs possess a short stem plus
a 2-nt 30 overhang (also known as the nuclear cropping step)
[20]. After being exported from the nucleus to the cytoplasm,
pre-miRNAs are processed by Dicer (an RNase III enzyme)
to produce mature miRNAs, which are incorporated into
the RNA-induced silencing complex (RISC) to repress the
expression of the target genes or bind directly to DNA
preventing transcription [21–24].Table 1 Summary of pluripotency or differentiation associated miRNA
Name Validated targets Cell type
miR-302a CyclinD1 hESCs
miR-302 NR2F2 hESCs
miR-302b, miR-372 TGFBR2, RHOC hiPSCs
miR-291b-5p, miR-293 P65 mESCs
miR-138 P53 miPSCs
miR-145 Oct4, Sox2, Klf4 hESCs
miR-125, miR-181 Cbx7 mESCs
Let-7b TLX, CyclinD1 Neural stem
miR-9 Stathmin hNPCs
miR-18, let-7 Smad2, Acvr1b, Lin28 mESCs
miR-27b Pax3 Muscle stem
miR-375 Hnf1b, Sox9 hESCs
Panct1-3 Oct4 mESCs
lincRNA-RoR P53 hiPSCs
Tsix PRC2 mESCs
Mistral MLL1 mESC
lncRNA_N1, lncRNA_N3 SUZ12, REST hESCsIn contrast to miRNAs, some lncRNAs are remarkably
similar to messenger RNAs (mRNAs). lncRNAs are
transcribed by RNA polymerase II, capped, spliced and get
polyadenylated like mRNAs, although they cannot act as tem-
plates for protein synthesis [25]. lncRNAs are able to activate
or repress gene expression at multiple levels through diverse
mechanisms. For example, lncRNAs can recruit repressive
(e.g., PRC2) and activating (e.g., the Trithorax group) chro-
matin modiﬁers at the DNA level much like molecular scaf-
folds, leading to regulation of target gene expression [26–29].
At the RNA level, lncRNAs play a role in post-transcriptional
events during gene expression and contribute to splicing,
mRNA translation and mRNA degradation [30–33]. In addi-
tion, certain lncRNAs can inhibit miRNA function, which
indirectly enhances protein expression of miRNA targets
[34]. Along with the growing understanding of the signiﬁcance
of ncRNAs in mammalian cell differentiation and human dis-
eases [35,36], accumulating examples are being identiﬁed that
illustrate the speciﬁc importance of short and long ncRNAs
in PSCs. In this review, we focus on the recent advances in
our understanding of miRNAs and lncRNAs, in the induction,
maintenance and differentiation of PSCs.ESC-speciﬁc miRNA family
Numerous studies identiﬁed a set of ESC-speciﬁc miRNAs
that were preferentially expressed in ESCs and downregulated
during differentiation into embryoid bodies [37,38]. The
expression signature of ESCs has been characterized (Table 1
and Figure 1). The requirement of miRNAs in ESC self-renew-
al and differentiation was demonstrated by ESCs lacking the
miRNA-processing enzymes, Dicer or DGCR8. Dicer- or
Dgcr8-null ESCs exhibited reduced cell proliferation due to
G1 cell cycle arrest and resistance to differentiation through
embryoid body formation or retinoic acid induction [39,40].
miRNAs, miR-195 and miR-372 participate in hESC cell cycle
control by depleting the two main miRNA processing
enzymes, Dicer and Drosha [41].
In addition, two clusters of miRNAs––miR-302 cluster
and mouse miR-290-295/human miR-371-373 cluster––weres and lncRNAs
Function Ref
Regulate cell cycle, promote self-renewal [42]
Maintain pluripotency [43]
Accelerate mesenchymal to epithelial transition [57]
Maintain pluripotency and self-renewal [46]
Promote reprogramming [63]
Induce diﬀerentiation [77]
PRC1-mediated diﬀerentiation [78]
cells Reduce proliferation and diﬀerentiation [79]
Coordinate proliferation and migration [81]
Mesoderm diﬀerentiation [71,84]
cells Myogenic diﬀerentiation [88]
Endoderm diﬀerentiation [92]
Maintain pluripotency [97]
Promote reprogram [99]
X-chromosome inactivation [103]
Germ layer diﬀerentiation [104]
Neurogenesis [105]
Pluripotency Differentiation 
Differentiated cellsPluripotent cells
Yamanaka factors
and/or 
miR-302-367, 
miR-290-295, 
miR-371-373, 
Panct1-3,  
lincRNA-RoR
miR-302-367, 
miR-34, miR-200c, 
miR-92, miR-141,  
miR-138, lincRNA-RoR 
Let-7,miR-145, 
miR-125,Tsix 
miR-181, Mistral, 
lncRNA_N1,  
lncRNA_N3  
ESCC miRNAs lin28 
let-7 Pluripotency 
genes
Figure 1 Summary of the published interactions between pluripotency and differentiation associated miRNAs and lncRNAs
miRNAs and lncRNAs that are upregulated in pluripotency are indicated in green, miRNAs that are downregulated in pluripotency are in
purple, miRNAs and lncRNAs regulating the somatic reprogramming are in blue. ESCC miRNAs and let-7 miRNAs that form a
feedback loop in regulating ESC pluripotency and differentiation are showed in red.
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miRNAs on chromosome 3/4 in human), consists of highly ex-
pressed ESC-speciﬁc miRNAs including some of the most
commonly studied miRNAs [42]. Pluripotency factors Oct4
and Sox2 can bind to a conserved promoter region of the
miR-302 to initiate its expression [42]. miR-302a can inhibit
the expression of G1 regulator cyclin D1, which contributes
to the increased population of hESCs in S phase and regulating
the cell cycle of ESCs, thereby promoting self-renewal and
pluripotency [42]. A recent study found that in undifferentiated
ESCs, Oct4 and miR-302, directly inhibit the expression of
nuclear receptor subfamily 2, group F, member 2 (NR2F2;
COUP-TFII) at the transcriptional and post-transcriptional
levels, respectively. As a positive feedback loop, NR2F2
directly inhibits Oct4 expression [43].
The human homolog of the mouse miR-290-295 cluster,
which also forms a tight genomic cluster (miR-371-373 clus-
ter), is speciﬁcally expressed in hESCs, which is upregulated
in several human tumors [44]. A recent study indicated that
several Wnt-signaling pathway genes, including Dickkopf-1
(DKK1), TGF-beta type II receptor (TGFBR2), B cell trans-
location gene 1 (BTG1), and left right determination factor 1
(LEFTY1), were direct targets of miR-372 and -373 [45]. The
expression of the miR-371-373 cluster was transactivated via
the Wnt/b-catenin pathway by directly binding b-catenin/
LEF1 to the miR-371-373 promoter. These ﬁndings elucidate
a novel beta-catenin /LEF1 - miR-372 and -373-DKK1
regulatory feedback loop, which likely plays a crucial role in
ESC maintenance [45]. Luningschror et al. reported that
overexpression of the NF-kB subunit p65 results in the loss
of pluripotency and differentiation of ESCs, as well as theepithelial to mesenchymal transition [46]. Interestingly, the
miR-290 cluster, speciﬁcally miR-291b-5p and miR-293,
targets the p65 coding sequence to repress its translation,
which may also contribute to regulatory networks in
pluripotency [46].
The seed sequence of miRNAs is about 6–8 nt in length,
which is thought to be the most important feature for miRNA
target speciﬁcity [47–49]. Interestingly, previous studies
showed that several miRNAs from different clusters including
miR-106, miR-302-367 and miR-290 have similar seed se-
quences (AAGUGCU) and are all upregulated in ESCs, sug-
gesting that they may repress similar pools of mRNAs to
maintain the stem cell state [50].miRNAs function during somatic cell
reprogramming
Since the Yamanaka’s group claimed that somatic cells can be
reprogrammed into iPSCs by expressing four transcription fac-
tors Oct4, Sox2, c-Myc and Klf4 (also known as the Yama-
naka factors), scientists have tried different methods to
obtain the iPSCs [4,51–55].
Several miRNAs have been shown to increase the efﬁciency
of reprogramming when expressed along with a combination
of the four or fewer Yamanaka factors [56,57]. For example,
MYC can be regulated by the miR-17-92 cluster, and overex-
pression of MYC leads to increased levels of miR-92 [58].
miR-92 belongs to the miR-17-92 cluster, which is upregulated
in cancer [58]. Studies have shown that there are differences in
the miRNA patterns between human iPSCs (hiPSCs) and
278 Genomics Proteomics Bioinformatics 11 (2013) 275–283hESCs, suggesting that ﬁbroblasts may not be induced to a
state identical to that of ESCs [59,60]. To better appreciate
such differences in the expression pattern of miRNAs, Neveu
and his colleagues proﬁled the miRNA expression in different
cell types, including hESCs, iPSCs, differentiated cells, cancer
cells and glioma biopsies [61]. These researchers identiﬁed two
distinct categories of miRNA patterns in pluripotent cells,
regardless the reprogrammed cells were derived from somatic
or embryonic cells. The results are surprising, since these two
cell categories differ in the status of their p53 network. The
overexpression of miR-92 and miR-141, the p53 regulatory
miRNAs, in iPSCs conferred alterations in the miRNA proﬁle
[61]. As p53 targets, miR-34 (a, b and c) can cooperate with
p21, another target of p53, to restrain somatic reprogramming
[62]. Numerous studies reported that as a tumor suppressor,
p53 prevents pluripotency during somatic reprogramming
[61,62]. In our study, we demonstrated that the ectopic expres-
sion of miR-138 dramatically increased the efﬁciency of iPSC
formation by targeting the 30 UTR of p53 [63]. Surprisingly,
overexpression of the miR-302-367 cluster can directly repro-
gram human and mouse somatic cells into a PSC state without
exogenous transcription factors, and the reprogramming efﬁ-
ciency is greatly increased compared to that induced by the
Yamanaka factors [64]. Further study showed that the miR-
302-367 cluster can activate Oct4 gene expression and suppress
HDAC2 activity, which may cooperate to reprogram somatic
cells to pluripotency [64]. Meanwhile, mature double-stranded
miRNAs (combination of miR-200c, miR-302s and miR-369s
family) can also reprogram mouse and human cells to a plurip-
otent state by using transfection reagents, which may be safer
for biomedical research by avoiding the vector-based gene
transfer system [65].
Furthermore, other reports conﬁrm that these miRNAs
function in part through increasing the mesenchymal-epithelial
transition (MET) by targeting at least the TGFBR2 and Ras
homolog gene family, member C (RHOC), to enhance repro-
gramming [57]. MET occurs during organ development and
also at an early stage during the reprogramming of ﬁbroblasts
[57,66,67]. Further study revealed that miR-302 signiﬁcantly
decreased the activities of amine oxidase ﬂavin-containing do-
main protein 2 (AOF2) and DNA methyltransferase 1
(DNMT1). In addition, in conjunction with the co-suppression
of methyl-speciﬁc proteins (MECP1/2), miR-302 resulted in
global genomic DNA demethylation and histone H3 lysine
4(H3K4) modiﬁcation [68]. Modiﬁcation of chromosomal his-
tones can either activate or silence genes; in particular, the
methylation level of H3K4 is likely to be important for the efﬁ-
cient reprogramming of pluripotency genes [69].
One miRNA can have many target genes. Therefore, the
mechanisms of miRNA-mediated gene regulation are partic-
ularly complex during the somatic cell reprogramming pro-
cess. The studies described above found that various
miRNAs can improve or restrain the efﬁciency of induction
during somatic cell reprogramming. However, the mechanism
by which genes are targeted by miRNAs remains largely
unknown.
miRNAs act as suppressors of the pluripotent state
miRNAs are critical for embryonic development and pluripo-
tency maintenance and are involved in cell fate decisions aswell. ESC-speciﬁc miRNAs have been described previously
[37,38]. Nonetheless, miRNAs can also promote the differenti-
ation of ESCs into the three germ layers––ectoderm, mesoderm
and endoderm.
The let-7 miRNAs are broadly expressed in differentiated
tissues and are increased during ES cell differentiation
[70,71] (Table 1 and Figure 1). At the early differentiation
stage of ESCs, expression of Oct4, Sox2, Nanog and other
pluripotency genes are downregulated, which leads to the
downregulation of the ES cell-speciﬁc cell cycle-regulating
(ESCC) miRNAs and Lin28. Lin28, an RNA-binding protein,
is a posttranscriptional repressor of let-7 miRNA biogenesis
[72]. Therefore, the downregulation of Lin28 dramatically in-
creases the expression of let-7 miRNAs. By targeting the 30
UTR of Lin28, let-7 may inhibit the translational initiation
of the genes downstream of Oct4, Sox2, Nanog and transcrip-
tion factor 3 (Tcf3), thereby accelerating the differentiation of
ESCs [73,74]. Further study demonstrated that TUT4 is the
uridylyl transferase for the let-7 precursor, which adds an oli-
gouridine tail to downstream targets of the let-7 miRNAs,
blocking the biogenesis of let-7 miRNA at the dicing step [75].
Expression of miR-145 is low in self-renewing hESCs,
which is highly upregulated during differentiation [76]. A
recent study reported that increased miR-145 expression
inhibits hESC self-renewal and induces lineage-restricted
differentiation [76]. Furthermore, Xu et al. demonstrated that
endogenous miR-145 binds to the 3’ UTR of the pluripotency
genes Oct4, Sox2 and Klf4. Interestingly, as part of a double-
negative feedback loop, the miR-145 promoter, is bound and
repressed by Oct4 in hESCs [77].
The polycomb group (PcG) contains multiple homologs of
the polycomb repressive complex 1 (PRC1) components
including ﬁve orthologs of the Drosophila polycomb protein
(Cbx2, Cbx4, Cbx6, Cbx7 and Cbx8), and is critical for ES plu-
ripotency and differentiation. A recent study demonstrated
that Cbx7 is the primary polycomb ortholog of the PRC1 com-
plexes in ESCs and knockdown of Cbx7 expression in ESCs
can induce differentiation and increase expression of lineage-
speciﬁc markers [78]. The miR-125 and miR-181 families are
regulators of Cbx7, and overexpression of these miRNAs
accelerates ESC differentiation [78].
Studying ESCs can help us understand how miRNAs play a
role in suppressing the pluripotent gene expression. However,
to clarify the speciﬁc role of microRNA in ESC differentiation,
further study is needed.
Role of miRNAs in stem cell lineage determination
The iPSC technology provides an unlimited source of stem
cells to promote the clinical applications of cell therapy. How-
ever, one of the biggest challenges to such clinical application
is differentiating these pluripotent cells into the ﬁnal functional
cells of a speciﬁc organ. A further understanding of miRNAs
demonstrated that the function of different cell types is associ-
ated with a unique miRNA expression pattern.
The let-7 family plays an important role in the ectoderm
lineage differentiation of ESCs. Further study demonstrated
that the let-7b miRNA regulates neural stem cell proliferation
and differentiation by targeting the stem cell regulator TLX
and the cell cycle regulator cyclin D1 [79]. Expression of mus-
ashi 1 (Msi1), an RNA-binding protein, is increased during the
Jia W et al / Regulatory Non-coding RNAs in Pluripotent Stem Cells 279early neural differentiation of ESCs. Msi1 can enhance Lin28
localization to the nucleus and block let-7 family member
miR-98 in the nuclear cropping step, thus affecting early neu-
ral differentiation of ESCs [80]. miR-9, a brain-speciﬁc miR-
NA, is expressed in human neural progenitor cells (hNPCs)
that are derived from hESCs. Further results suggest that
miR-9 regulates the proliferation and migration of hNPCs
by directly targeting the microtubule-related gene stathmin
[81]. The highly expressed miR-371-373 cluster in PSCs has
also been reported to play a critical role in human PSC neuro-
genic differentiation behavior [82,83].
Another group found that let-7 and miR-18 downregulated
Acvr1b and Smad2, respectively, to increase the mesoderm at
the expense of endoderm in mouse ESCs (mESCs) [84].
Expression of miR-125b is upregulated in patients with leuke-
mia and can regulate hematopoiesis by targeting Lin28 in
mouse hematopoietic stem cells and progenitor cells [85]. Ivey
and colleagues demonstrated that miR-1 and miR-133 can reg-
ulate mesoderm formation and cardiac muscle differentiation
by suppressing the gene expression in desired lineages [86,87].
Pax3, a regulator of skeletal muscle stem cells, is required for
the maintenance of muscle cell differentiation. miR-27b down-
regulates the Pax3 protein levels by directly targeting the 30
UTR of Pax3 and accelerates myogenic differentiation in mus-
cle stem cells [88]. However, a recent study demonstrated that
miR-489 is a quiescence-speciﬁc miRNA in the satellite cell
lineage. The highly expressed miR-489 in quiescent satellite
cells decreased quickly during satellite cell activation. Further
results have shown that miR-489 suppresses the oncogene Dek
at the posttranscriptional level, which may be associated with
the mechanism for maintaining the quiescent state of a stem
cell population [89].
miR-24 and miR-10a were upregulated to inhibit endoder-
mal differentiation during NaButyrate induction of hESCs
[90]. Joglekar et al. showed that the expression of four islet-
speciﬁc miRNAs including miR-7, miR-9, miR-375 and miR-
376 was high during human pancreatic islet development
[91]. Overexpression of miR-375 can downregulate the expres-
sion of gut-endoderm/pancreatic progenitor-speciﬁc markers,
hepatocyte nuclear factor 1 beta(Hnf1b) and Sox9, during
endodermal differentiation of hESCs. These data indicate that
miR-375 may regulate hESC differentiation toward pancreatic
islet cells [92].
Taken together, as one miRNA can target more than one
gene, the role of miRNAs in cell differentiation is not only re-
lated to the level of its own expression but also has a close rela-
tionship with factors like the differentiation system, cell type
and microenvironment.
lncRNAs in ESC pluripotency and somatic cell
reprogramming
Recent studies have identiﬁed over 900 so-called lincRNAs in
mESCs and hESCs, which potentially control the self-renewal
and pluripotency of ESCs [93,94]. Intriguingly, more than 100
lincRNAs (with proximal genomic targets located less than
10 kb genomic distance from a gene to the binding site) in
mESCs appear to be directly bound by ESC-speciﬁc transcrip-
tion factors, such as Sox2, Oct4 and Nanog [95]. Lipovich’s
group observed two lincRNAs that are regulated by Oct4 and
Nanog and are essential for maintaining pluripotency. Theinhibition or misexpression of these two lincRNAs leads to dra-
matic changes in the expression of Oct4 and Nanog, indicating
the involvement of a feedback loop in the regulatory mecha-
nism [95]. To further examine the role of lincRNAs in pluripo-
tency, Guttman et al. performed loss-of-function studies on 147
lincRNAs using lentiviral-based shRNAs in mESCs [96]. Of
these lincRNAs, 26 showed involvement in the maintenance
of pluripotency. After deleting these lincRNAs, a reduced Na-
nog promoter activity was discovered and expression pattern in
mESCs was similar to that in the differentiated cell types, sug-
gesting that these lincRNAs repress differentiation programs in
mESCs. Another large-scale screen of functional lincRNAs in
mESCs was achieved by using RNA interference (RNAi) with
transcript localization. Consequently, three non-coding tran-
scripts, Panct1-3, were identiﬁed as modulators of mESC pluri-
potency based on reduced Oct4 promoter activity [97]. Recent
ﬁndings showed that lincRNA-RoR (regulator of reprogram-
ming, formerly called lincRNA-ST8SIA3) shares miRNA
response elements with Oct4, Sox2 and Nanog, and that
lincRNA-RoR prevents these core transcription factors from
miRNA-mediated suppression in self-renewing hESCs [98].
Together, these ﬁndings connect lincRNAs to the regulatory
networks that maintain ESC identity.
In addition to maintaining ESC pluripotency, lncRNAs are
involved in the generation of iPSCs (Table 1 and Figure 1).
This cellular reprogramming is accompanied by an extensive
global remodeling of the epigenome. The research group, led
by Loewer et al., found that the expression proﬁles of lincR-
NAs in iPSCs were similar to those in ESCs but not to those
in the somatic cells of origin, such as ﬁbroblasts and hemato-
poietic stem cells [99]. Further study showed that expression of
10 lincRNAs was elevated in iPSCs compared with ESCs, sug-
gesting that their increased expression may promote repro-
gramming [99]. Promoter loci of 3 iPSC-enriched lincRNAs,
including lincRNA-SFMBT2, lincRNA-VLDLR and lin-
cRNA-RoR, are bound by Oct4, Sox2 and Nanog. In addi-
tion, knockdown of Oct4 led to downregulation of these
lincRNAs, suggesting that their expression is directly regulated
by the key pluripotency transcription factors. The depletion of
lincRNA-RoR resulted in a 2–8-fold decrease in the number of
emerging iPSC colonies. Conversely, overexpression of lin-
cRNA-RoR increased the efﬁciency of iPSC colony formation.
Microarray gene expression analysis demonstrated that knock-
down of lincRNA-RoR led to p53 upregulation, which induces
oxidative stress, DNA damage and cell death, conﬁrming the
role of lincRNAs in the induction of pluripotency by promot-
ing the survival of iPSCs [99].
lncRNAs are implicated in the differentiation
of PSCs
lncRNAs can regulate the differentiation of ESCs as well. For
example, X-inactive speciﬁc transcript (Xist) plays a role in X-
chromosome inactivation (XCI) during female ESC differenti-
ation. In placental mammals, XCI randomly inactivates one of
the two female X chromosomes to obtain the proper gene dos-
age of X-linked genes in females as compared with males [100].
In female ESCs, Oct4, Sox2 and Nanog bind to intron 1 of
Xist to suppress its expression, whereas the antagonizing
lncRNA Tsix is activated by the pluripotency factors Oct4,
Sox2, Rex1, c-Myc and Klf4 [101,102]. Upon differentiation,
280 Genomics Proteomics Bioinformatics 11 (2013) 275–283downregulation of the pluripotency factors initiates the expres-
sion of Xist, which later recruits chromatin regulators such as
PRC2 to mediate XCI [103]. In addition to Xist in the early
step of differentiation, certain other lncRNAs play important
roles in the later lineage commitment. Mixed lineage leukemia
1 (MLL1) is an epigenetic activator involved in embryonic
development and hematopoiesis [104]. Bertani et al. found that
the lncRNA Mistral is able to recruit MLL1 to chromatin and
subsequently induce the expression of the homeotic genes
Hoxa6 and Hoxa7 during mESC germ layer differentiation
[104]. Another study reported an essential role for lncRNAs
in neurogenesis. Cytoplasmic lncRNA_N2 promoted neuro-
genesis possibly by maintaining the expression of neurogenic
miRNAs, miR-125b and let-7a, since both of them are located
within the introns of lncRNA_N2. Additionally, nuclear
lncRNA_N1 and lncRNA_N3 were identiﬁed to physically
interact with nuclear factors REST and SUZ12, respectively,
suggesting their potential roles in regulating neuronal differen-
tiation [105].
Expression of lncRNAs is correlated with the full develop-
ment potential of iPSCs. In most of the iPSC clones, the
lncRNA Gtl2, which belongs to the Dlk1–Dio3 imprinted lo-
cus, is aberrantly silenced by DNA hypermethylation and his-
tone hypoacetylation [106,107]. The Gtl2 gene is maternally
expressed and its expression is thought to negatively regulate
the expression of paternal Dlk1 gene, which is located within
the same gene cluster and gets involved in fetal growth. In
addition, a total of 26 miRNAs all localized to the Dlk1–
Dio3 cluster are differentially expressed in non-4n complemen-
tation-competent and 4n complementation-competent iPSC
lines [106]. The silenced status of this cluster in iPSCs is closely
correlated with the developmental failure of these iPSCs. In
contrast, iPSC clones with normal Dlk1–Dio3 cluster expres-
sion contributed to high-grade chimaeras and yielded viable
all-iPSC mice. Interestingly, when an iPSC clone with silenced
Dlk1–Dio3 was treated with a histone deacetylase inhibitor val-
proic acid (VPA), the locus that includes Gtl2 got reactivated,
thus recovering the capability of this clone to support full-term
development of all-iPSC mice.
Future perspectives
In recent years, the miRNAs and lncRNAs have been emerg-
ing as important components of gene regulation and have be-
come the new hotspot of current molecular biology. Somatic
cell reprogramming technology renders terminally-differenti-
ated cells to revert to a pluripotent state, thus injecting new
vitality into the ﬁeld of stem cell research. Studies have shown
that the regulatory interactions between ESC-speciﬁc miRNAs
and their targets in the cell cycle, DNA methylation,
mesenchymal to epithelial transition and apoptosis pathways
inﬂuence stem cell pluripotency and somatic cell reprogram-
ming and differentiation. A large number of miRNA and
lncRNA sequences have been obtained via high-throughput
sequencing technologies. However, the underlying molecular
mechanism of ESC differentiation and pluripotency mainte-
nance and somatic cell reprogramming still remains elusive.
Better understanding of the new functions and mechanisms
of miRNAs and lncRNAs in these processes would be condu-
cive to achieving better appreciation of epigenetics and even
more extensive impact on life sciences and biomedical research.Competing interests
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